Search
for
Sort by
Community 30 of 58
- We need to keep these snake oil companies accountable.
- New Research- Creatine Increasing Scalp DHT Without Corresponding Serum DHT Increase
- Please explain this Minoxidil phenomena
- Thoughts on this Article: Post-Finasteride and Neurological Effects
- AH-001 another topical AR degrader beside GT20029, completed Phase I
- Is there any role for topical DHT antagonists, or does a 5-AR inhibitor remove the need for them as therapy
- 1 year 5-ar. Blood test results
- Why does this industry still revolve around 5-AR inhibitors?
- 27M Struggling with 5-Month Treatment Limit on Minoxidil and Finasteride, Seeking AR Blocker Advice
- BREAKTHROUGH: I’m a radiochemist and discovered a radioactive isotope scalp serum that OUTPERFORMS Minoxidil and 5-AR inhibitors! (Lab Data Inside)
- Why I believe alfatrodial and fluridil combined with minoxidil is an effective treatment. My experience.
- NMN Promotes Cell Proliferation and Hair Growth by Reducing Oxidative Stress
- Breaking hair loss news! GT20029 is a resounding success!
- How to know if shedding is from tren or minoxidil?
- Androgenetic alopecia is a skin disease: DHT-mediated skin disorders
- Question about clascoterone acne cream
- EMA is re-examining Winlevi (clascoterone at lower concentration)
- Androgen degraders for hair loss
- Pyrilutamide just launched internationally, and all you're doing is hating
- Topical Dutasteride - Non-Hormonal, Side Effect Free 5ARI?
- Kintor's email response to me, regarding false advertising, and my proposal for them to develop a topical dut formulation with meaningful efficacy.
- Fagron TrichoTest says Finasteride won't help
- Will finasteride halt my beard development ?
- Stopped topical Minox and Fin for 2 years, started again and gained my old status back
- Why are there no FDA approved NSAA's yet?
- bro where tf is GT20029, Q1 2024 is over already
- PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- Latanoprost- an effective medication
- IGFBP‐rP1 is a potential therapeutic target in androgenic alopecia